Effectiveness of a Bivalent, Killed Whole-cell Based Oral Cholera Vaccine (Shanchol) Delivered Through Community-based Mass Vaccination Campaign in a High-risk Population in India: Matched Case-control Studies.

Trial Profile

Effectiveness of a Bivalent, Killed Whole-cell Based Oral Cholera Vaccine (Shanchol) Delivered Through Community-based Mass Vaccination Campaign in a High-risk Population in India: Matched Case-control Studies.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Cholera vaccine inactivated (Primary)
  • Indications Cholera
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jun 2013 Planned number of patients changed from 48 to 240 as reported by ClinicalTrials.gov.
    • 04 Jun 2013 Planned End Date changed from 1 Jun 2014 to 1 Mar 2014 as reported by ClinicalTrials.gov.
    • 01 Mar 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top